结肠炎诱发肝脏屏障功能障碍的研究进展

doi:10.16352/j.issn.1001-6325.2022.01.022

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (1): 149-153.doi: 10.16352/j.issn.1001-6325.2022.01.022

结肠炎诱发肝脏屏障功能障碍的研究进展

树梦萱^1,2, 袁方晨^1,2, 周梦琪^1,2, 涂世盐^1,2, 许玥^1,2, 秦红岩^1*

1.兰州大学第一医院药剂科,甘肃兰州 730000;
2.兰州大学第一临床医学院,甘肃兰州 730000

收稿日期:2020-08-14 修回日期:2021-03-01 出版日期:2022-01-05 发布日期:2022-01-05
通讯作者: ^* candyqinhy@163.com
基金资助:
国家自然科学基金(81770657);中央高校基本科研资金(lzujbky-2018-56);兰州大学大学生创新创业行动计划(20190060169);兰州大学第一临床医学院“卓越计划”项目(20190060169)

Research progress in colitis-induced hepatic barrier dysfunction

SHU Meng-xuan^1,2, YUAN Fang-chen^1,2, ZHOU Meng-qi^1,2, TU Shi-yan^1,2, XU Yue^1,2, QIN Hong-yan^1*

1. Department of Pharmacy, the First Hospital of Lanzhou University, Lanzhou 730000;
2. the First Clinical Medical College, Lanzhou University, Lanzhou 730000, China

Received:2020-08-14 Revised:2021-03-01 Online:2022-01-05 Published:2022-01-05
Contact: ^* candyqinhy@163.com

摘要/Abstract

摘要： 肝脏屏障是肝脏抵御外源性有害物质侵袭的主要结构,在维持肝脏分泌功能,调控胆汁转运及细胞间信息传递中发挥重要作用。内毒素、炎性因子及胆汁酸等诱发肝脏屏障蛋白改变及屏障功能障碍,可能参与结肠炎性肝病发生。探究结肠炎对肝脏屏障的影响及机制,从肝脏屏障角度阐释结肠炎性肝病的发生机制有望为其防治提供线索和依据。

关键词: 结肠炎, 肝脏屏障, 内毒素, 胆汁酸, 炎性因子

Abstract: Liver barrier functions as a main structure to protect the liver from exogenous harmful substances and play an important role in maintaining secretion function, regulating bile transport and intercellular information transmission. Liver barrier protein alteration and barrier dysfunction can be induced by endotoxin, inflammatory cytokines and bile acids, which may be involved in the occurrence of colitis-related liver diseases. To explore the outcomes and underlying mechanism of intestinal inflammation on liver barrier function may support the understanding of pathogenesis of colitis-related liver diseases and thus provide clues and basic information for the prevention and treatment of colitis-related liver diseases.

Key words: colitis, liver barrier, endotoxin, bile acids, inflammatory cytokines

中图分类号:

R972

树梦萱, 袁方晨, 周梦琪, 涂世盐, 许玥, 秦红岩. 结肠炎诱发肝脏屏障功能障碍的研究进展[J]. 基础医学与临床, 2022, 42(1): 149-153.

SHU Meng-xuan, YUAN Fang-chen, ZHOU Meng-qi, TU Shi-yan, XU Yue, QIN Hong-yan. Research progress in colitis-induced hepatic barrier dysfunction[J]. Basic & Clinical Medicine, 2022, 42(1): 149-153.

参考文献

[1]Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders [J]. J Crohns Colitis, 2017, 11:649-670.
[2]Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease [J]. Gut, 2019, 68:547-561.
[3]Gizard E, Ford AC, Bronowicki JP, et al. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease [J]. Aliment Pharmacol Ther, 2014, 40:3-15.
[4]Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and manage-ment of crohn's disease 2016: Part 1: diagnosis and medical management [J]. J Crohns Colitis, 2017, 11:3-25.
[5]Dongaonkar RM, Stewart RH, Quick CM, et al. Hepatic transudation barrier properties [J]. Microcirculation, 2018, 25:1043-1057.
[6]Şimşek T, Ersoy ÖF, Özsoy Z, et al. Effect of sildenafil citrate on the liver structure and function in obstructive jaundice: an experimental study [J]. Turk J Surg, 2018, 34: 111-116.
[7]Mazzon E, Puzzolo D, Caputi AP, et al. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis [J]. Mol Med, 2002, 8:353-366.
[8]Mazzon E, Cuzzocrea S. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis [J]. Cell Mol Biol, 2003, 49:45-57.
[9]Cheng C, Tan J, Qian W, et al. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: attention to the gut-vascular barrier dysfunction [J]. Life Sci, 2018, 209:157-166.
[10]饶艳霞, 陈洁, 吴亦, 等. DSS诱导溃疡性结肠炎大鼠模型肝脏紧密连接蛋白的表达改变[J]. 临床儿科杂志, 2012, 30:967-972.
[11]Lora L, Mazzon E, Martines D, et al. Hepatocyte tight-junctional permeability is increased in rat experimental colitis [J]. Gastroenterology, 1997, 113:1347-1354.
[12]Balistreri WF. Hepatobiliary complications of inflammatory bowel disease: overview of the issues [J]. Inflamm Bowel Dis, 1998, 4:220-224.
[13]Gabele E, Dostert K, Hofmann C, et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH [J]. J Hepatol, 2011, 55:1391-1399.
[14]Reiling J, Bridle KR, Gijbels M, et al. Low-dose lipopolysaccharide causes biliary injury by blood biliary barrier impairment in a rat hepatic ischemia reperfusion model [J]. Liver Transpl, 2017, 23:194-206.
[15]Correa PR, Guerra MT, Leite MF, et al. Endotoxin unmasks the role of gap junctions in the liver [J]. Biochem Biophys Res Commun, 2004, 322:718-726.
[16]Theodorakis NG, De Maio A. Cx32 mRNA in rat liver: effects of inflammation on poly(A) tail distribution and mRNA degradation [J]. Am J Physiol, 1999, 276:R1249-1257.
[17]De Maio A, Gingalewski C, Theodorakis NG, et al. Interruption of hepatic gap junctional communication in the rat during inflammation induced by bacterial lipopolysac-charide [J]. Shock, 2000, 14:53-59.
[18]Romualdi A, Niessen H, Dombrowski F, et al. Quantita-tive analysis of gap-junctional intercellular communication in precision-cut mouse liver slices [J]. Cell Tissue Res, 2002, 307:315-320.
[19]Ochoa-Sanchez R, Rose CF. Pathogenesis of hepatic encephalopathy in chronic liver disease [J]. J Clin Exp Hepatol, 2018, 8:262-271.
[20]Balasubramaniyan V, Dhar DK, Warner AE, et al. Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure [J]. J Hepatol, 2013, 58:1194-1200.
[21]Zeng H, Umar S, Rust B, et al. Secondary bile acids and short chain fatty acids in the colon: a focus on colonic microbiome, cell proliferation, inflammation, and cancer [J]. Int J Mol Sci, 2019, 20:1214-1233.
[22]de Vries E, Beuers U. Management of cholestatic disease in 2017 [J]. Liver Int, 2017, 37:123-129.
[23]Takakuwa Y, Kokai Y, Sasaki K, et al. Bile canalicular barrier function and expression of tight-junctional mole-cules in rat hepatocytes during common bile duct ligation [J]. Cell Tissue Res, 2002, 307:181-189.
[24]Yang T, Mei H, Xu D, et al. Early indications of ANIT-induced cholestatic liver injury: alteration of hepatocyte polarization and bile acid homeostasis [J]. Food Chem Toxicol, 2017, 110:1-12.
[25]Khan HA, Ahmad MZ, Khan JA, et al. Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance [J]. Hepatobiliary Pancreat Dis Int, 2017, 16:245-256.

结肠炎诱发肝脏屏障功能障碍的研究进展

Research progress in colitis-induced hepatic barrier dysfunction

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李潇潇, 舒祥兵, 张莉. 胆固醇代谢与非酒精性脂肪性肝炎的研究进展[J]. 基础医学与临床, 2022, 42(7): 1134-1138.
[2]	努尔曼·阿卜杜克力木, 韩正风, 马艳. 医院-社区-家庭一体化康复模式对老年衰弱综合征患者的影响[J]. 基础医学与临床, 2022, 42(4): 640-645.
[3]	李小丽, 陈慧玲, 王小春, 韩悌云, 张德奎. 二氢杨梅素对实验性结肠炎小鼠调节性B细胞的影响[J]. 基础医学与临床, 2022, 42(2): 274-281.
[4]	房婷李响刘洁王皓. 鼠李糖乳杆菌通过调节肠道微生物群缓解造血干细胞移植后肝脏移植物抗宿主病[J]. 基础医学与临床, 2021, 41(9): 1303-1308.
[5]	王少鑫崔立红李晓伟刘新尧罗哲闫志辉. 敲低Ube2w增加葡聚糖硫酸钠诱导的小鼠溃疡性结肠炎的易感性[J]. 基础医学与临床, 2021, 41(7): 946-950.
[6]	李雨芯余雪嫣黄雪. 白芨多糖上调溃疡性结肠炎小鼠肠黏膜紧密连接蛋白occludin的表达[J]. 基础医学与临床, 2021, 41(7): 941-945.
[7]	宋茜黄雪覃蒙斌张君红井洁罗毅华李雨芯. STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达[J]. 基础医学与临床, 2021, 41(6): 792-798.
[8]	李春美赵微解相宏张伟虹杨佳卉李军刘晓军. 青稞酥油饮食对小鼠肠道菌群以及葡聚糖硫酸钠诱导的小鼠结肠炎症状的影响[J]. 基础医学与临床, 2021, 41(2): 203-208.
[9]	李倩刘纯华王晨怡谈娇娇马玉萍吕海宏. 炎性因子调控1型糖尿病血管内皮细胞功能的研究进展[J]. 基础医学与临床, 2021, 41(10): 1497-1501.
[10]	张雪梅李俊峰毛小荣. 胆汁酸代谢在肝硬化并发症中的研究进展[J]. 基础医学与临床, 2021, 41(1): 103-107.
[11]	黎笑兰张新广尹少萍. 白芨多糖抑制溃疡性结肠炎大鼠炎性反应与氧化应激[J]. 基础医学与临床, 2020, 40(2): 224-228.
[12]	何静宇温剑杨闯张永川. 瘦素调节胆汁酸代谢影响胆石形成[J]. , 2019, 39(12): 1723-1728.
[13]	徐志刚郑帅杨泽冉陈雪肖鲁瑶孙亚梅张杰. NR5A2减弱雨蛙素诱导大鼠胰腺腺泡细胞的炎性反应[J]. 基础医学与临床, 2018, 38(8): 1080-1087.
[14]	袁东周栋张安平李志勇张亚敏宋润泽. 骨膜蛋白siRNA转染抑制ox-LDL诱导的人主动脉内皮细胞系损伤[J]. 基础医学与临床, 2017, 37(7): 1026-1030.
[15]	张晓霞赵子健戴一凡李斌米树华. 多不饱和脂肪酸改善小鼠心肌脂质成分及缺血再灌注后线粒体功能[J]. 基础医学与临床, 2014, 34(11): 1503-1507.